African horse sickness in Thailand: Challenges of controlling an outbreak by vaccination

Safety and immunogenicity of a modified vaccinia virus Ankara vector vaccine candidate for Middle East respiratory syndrome: an open-label, phase 1 trial

(2020) Till Koch et al.   LANCET INFECTIOUS DISEASES

Randomized clinical trial examining safety and immunogenicity of heterologous prime-boost Ebola vaccines, Ad26.ZEBOV and MVA-BN-Filo: 12-month data from Nairobi, Kenya

(2019) Gaudensia Mutua et al.   JOURNAL OF INFECTIOUS DISEASES

African Horse Sickness: A Review of Current Understanding and Vaccine Development

(2019) Susan J Dennis et al.   Viruses-Basel

Plant-produced chimeric virus-like particles - a new generation vaccine against African horse sickness

(2019) Daria A. Rutkowska et al.   BMC Veterinary Research

The immunogenicity of recombinant vaccines based on modified Vaccinia Ankara (MVA) viruses expressing African horse sickness virus VP2 antigens depends on the levels of expressed VP2 protein delivered to the host

(2018) Eva Calvo-Pinilla et al.   ANTIVIRAL RESEARCH

African horse sickness virus (AHSV) with a deletion of 77 amino acids in NS3/NS3a protein is not virulent and a safe promising AHS Disabled Infectious Single Animal (DISA) vaccine platform

(2018) Piet A. van Rijn et al.   VACCINE

Assessment of reproducibility of a VP7 Blocking ELISA diagnostic test for African horse sickness

(2018) Manuel Durán-Ferrer et al.   Transboundary and Emerging Diseases

A single dose of African horse sickness virus (AHSV) VP2 based vaccines provides complete clinical protection in a mouse model

(2018) Mine Aksular et al.   VACCINE

Immunogenicity of plant-produced African horse sickness virus-like particles: implications for a novel vaccine

(2017) Susan J. Dennis et al.   PLANT BIOTECHNOLOGY JOURNAL

Dynamics of African horse sickness virus nucleic acid and antibody in horses following immunization with a commercial polyvalent live attenuated vaccine

(2017) C.T. Weyer et al.   VACCINE

Vaccination with recombinant Modified Vaccinia Ankara (MVA) viruses expressing single African horse sickness virus VP2 antigens induced cross-reactive virus neutralising antibodies (VNAb) in horses when administered in combination

(2017) Nicola Mary Manning et al.   VACCINE

Protective efficacy of multivalent replication-abortive vaccine strains in horses against African horse sickness virus challenge

(2017) Valeria Lulla et al.   VACCINE

Synthesis of empty african horse sickness virus particles

(2016) Sonja Maree et al.   VIRUS RESEARCH

Antiserum from mice vaccinated with modified vaccinia Ankara virus expressing African horse sickness virus (AHSV) VP2 provides protection when it is administered 48h before, or 48h after challenge

(2015) Eva Calvo-Pinilla et al.   ANTIVIRAL RESEARCH

Immunogenicity of recombinant VP2 proteins of all nine serotypes of African horse sickness virus

(2014) Yuta Kanai et al.   VACCINE

Vaccination of horses with a recombinant modified vaccinia Ankara virus (MVA) expressing African horse sickness (AHS) virus major capsid protein VP2 provides complete clinical protection against challenge

(2014) Berta Alberca et al.   VACCINE

Diagnostic accuracy of a duplex real-time reverse transcription quantitative PCR assay for detection of African horse sickness virus

(2013) Alan J. Guthrie et al.   JOURNAL OF VIROLOGICAL METHODS

Vaccination of mice with a modified Vaccinia Ankara (MVA) virus expressing the African horse sickness virus (AHSV) capsid protein VP2 induces virus neutralising antibodies that confer protection against AHSV upon passive immunisation

(2013) Eva Calvo-Pinilla et al.   VIRUS RESEARCH

African horse sickness in naturally infected, immunised horses

(2012) C. T. WEYER et al.   EQUINE VETERINARY JOURNAL

An African horse sickness virus serotype 4 recombinant canarypox virus vaccine elicits specific cell-mediated immune responses in horses

(2012) H. El Garch et al.   VETERINARY IMMUNOLOGY AND IMMUNOPATHOLOGY

Real-Time Fluorogenic Reverse Transcription Polymerase Chain Reaction Assay for Detection of African Horse Sickness Virus

(2011) Montserrat Agüero et al.   JOURNAL OF VETERINARY DIAGNOSTIC INVESTIGATION

A Modified Vaccinia Ankara Virus (MVA) Vaccine Expressing African Horse Sickness Virus (AHSV) VP2 Protects Against AHSV Challenge in an IFNAR −/− Mouse Model

(2011) Javier Castillo-Olivares et al.   PLoS One

Protective immunization of horses with a recombinant canarypox virus vectored vaccine co-expressing genes encoding the outer capsid proteins of African horse sickness virus

(2009) Alan J. Guthrie et al.   VACCINE